Karyopharm Therapeutics Inc - KPTI - stock price prediction, stock price target, analyst ratings from 7 analysts

Karyopharm Therapeutics Inc has a share price target of US$ 29, revenue growth forecast of 1.3%, and profit growth estimate of -61.4% for FY25, based on top 7 analyst calls.